Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 58 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

21%

12 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (17)
P 3 (5)
P 4 (7)

Trial Status

Recruiting29
Completed8
Not Yet Recruiting7
Unknown6
Active Not Recruiting5
Enrolling By Invitation2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT07572747Phase 3Not Yet RecruitingPrimary

Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countries

NCT07559994Not ApplicableActive Not Recruiting

Microvascular Dysfunction in Patients With Long-Covid Syndrome and Angina

NCT06736665Not ApplicableRecruiting

Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).

NCT07471867Phase 4RecruitingPrimary

Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention

NCT07329699Not ApplicableRecruiting

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

NCT07543185Not ApplicableNot Yet RecruitingPrimary

Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary Syndrome

NCT07472634CompletedPrimary

Evaluation of the Performance of the Cardiolens® Platform, Which Utilizes a Non-Invasive Combined Anatomical and Functional CCTA-based Assessment in Patients With Suspected CCS

NCT07428382Completed

Development and Validation of Care Pathway Quality Indicators for Stroke and Chronic Coronary Syndrome Using French Administrative Healthcare Database (DELIQUA-CNV)

NCT07392151Phase 3Not Yet Recruiting

Reversal to Normoglycemia by Treating Prediabetes

NCT06337461RecruitingPrimary

Computational mOdelliNg of myoCardial pERfusion to Improve ouTcome Prediction Based on cOronary Artery Stenosis and Atherosclerotic Plaque Burden Assessment by Computed Tomography

NCT04390126CompletedPrimary

COVID-19 Related Lockdown Effects On Chronic Diseases

NCT07195149Phase 3RecruitingPrimary

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

NCT06708000Phase 3Enrolling By InvitationPrimary

Personalized Evaluation of Susptected Myocardial Ischemia

NCT07291609RecruitingPrimary

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

NCT06896708Not ApplicableRecruitingPrimary

Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome

NCT05865600Not ApplicableRecruitingPrimary

Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome

NCT06742931Not ApplicableRecruitingPrimary

Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2

NCT06185530Not ApplicableRecruitingPrimary

SECURE Trial: Stress Echocardiography With Carotid Ultrasound vs Routine CT Coronary Angiography in Chronic Coronary Syndrome for Endpoints

NCT07182799Active Not Recruiting

Starring Optical Coherence Tomography During Percutaneous Coronary Intervention Guidance

NCT06808321Enrolling By InvitationPrimary

Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients

Scroll to load more

Research Network

Activity Timeline